Khan WH, Hashmi Z, Goel A, Ahmad R, Gupta K, Khan N, et al. COVID-19 pandemic and vaccines update on challenges and resolutions. Front Cell Infect Microbiol. 2021;11:690621.

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health Organization. Tracking SARS-CoV-2 variants. 2022. https://www.who.int/activities/tracking-SARS-CoV-2-variants. Accessed 12 Oct 2022.

Barranco R, Rocca G, Molinelli A, Ventura F. Controversies and challenges of mass vaccination against SARS-CoV-2 in Italy: medico-legal perspectives and considerations. Healthcare (Basel). 2021;9:1163.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. 2022. https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_21September2022.pdf. Accessed 21 Sep 2022.

Hadj HI. COVID-19 vaccines and variants of concern: a review. Rev Med Virol. 2022;32:e2313.

Google Scholar 

World Health Organization. The Sinovac-CoronaVac COVID-19 vaccine: what you need to know. 2022. https://www.who.int/news-room/feature-stories/detail/the-sinovac-covid-19-vaccine-what-you-need-to-know. Accessed 22 Feb 2023.

World Health Organization. The Sinopharm COVID-19 vaccine: what you need to know. 2022. https://www.who.int/news-room/feature-stories/detail/the-sinopharm-covid-19-vaccine-what-you-need-to-know. Accessed 22 Feb 2023.

Zar HJ, MacGinty R, Workman L, Botha M, Johnson M, Hunt A, et al. Natural and hybrid immunity following four COVID-19 waves: a prospective cohort study of mothers in South Africa. EClinicalMedicine. 2022;53:101655.

Article  PubMed  PubMed Central  Google Scholar 

Fan YJ, Chan KH, Hung IF. Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of different vaccines at phase 3. Vaccines (Basel). 2021;9:989.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Souza WM, Amorim MR, Sesti-Costa R, Coimbra LD, Brunetti NS, Toledo-Teixeira DA, et al. Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study. Lancet Microbe. 2021;2:e527-35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252–60.

Article  CAS  PubMed  Google Scholar 

Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty. 2021;10:132.

Article  PubMed  PubMed Central  Google Scholar 

Dadras O, SeyedAlinaghi S, Karimi A, Shojaei A, Amiri A, Mahdiabadi S, et al. COVID-19 vaccines’ protection over time and the need for booster doses; a systematic review. Arch Acad Emerg Med. 2022;10:e53.

PubMed  PubMed Central  Google Scholar 

Fu Y, Zhao J, Wei X, Han P, Yang L, Ren T, et al. Effectiveness and cost-effectiveness of inactivated vaccine to address COVID-19 pandemic in China: evidence from randomized control trials and real-world studies. Front Public Health. 2022;10:917732.

Article  PubMed  PubMed Central  Google Scholar 

Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med. 2021;385:e83.

Article  CAS  PubMed  Google Scholar 

Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28:202–21.

Article  CAS  PubMed  Google Scholar 

Balkan İ, Dinc HO, Can G, Karaali R, Ozbey D, Caglar B, et al. Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required. Ir J Med Sci. 2023;192:19–25.

Article  CAS  PubMed  Google Scholar 

Ge Y, Zhang WB, Wu X, Ruktanonchai CW, Liu H, Wang J, et al. Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories. Nat Commun. 2022;13:3106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pormohammad A, Zarei M, Ghorbani S, Mohammadi M, Aghayari Sheikh Neshin S, Khatami A, et al. Effectiveness of COVID-19 vaccines against Delta (B.1.617.2) variant: a systematic review and meta-analysis of clinical studies. Vaccines (Basel). 2021;10:23.

Article  PubMed  PubMed Central  Google Scholar 

Zeng B, Gao L, Zhou Q, Yu K, Sun F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2022;20:200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shao W, Chen X, Zheng C, Liu H, Wang G, Zhang B, et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis. Emerg Microbes Infect. 2022;11:2383–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.

Article  CAS  PubMed  Google Scholar 

International Vaccine Access Center. Results of COVID-19 vaccine effectiveness & impact studies: an ongoing systematic review, methods. https://view-hub.org/covid-19/effectiveness-studies. Accessed 8 Oct 2022.

World Health Organization. WHO COVID-19 case definition. 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2022.1. Accessed 22 Jul 2022.

World Health Organization. Living guidance for clinical management of COVID-19. 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2. Accessed 23 Aug 2022.

Chen X, Chen Z, Azman AS, Sun R, Lu W, Zheng N, et al. Neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants induced by natural infection or vaccination: a systematic review and pooled analysis. Clin Infect Dis. 2022;74:734–42.

Article  CAS  PubMed  Google Scholar 

Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8:2–10.

Article  PubMed  Google Scholar 

Movahedian M, Golzan SA, Ashtary-Larky D, Clark CCT, Asbaghi O, Hekmatdoost A. The effects of artificial- and stevia-based sweeteners on lipid profile in adults: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Crit Rev Food Sci Nutr. 2021:1–17. https://doi.org/10.1080/10408398.2021.2012641.

Sekizawa Y, Konishi Y, Kimura M. Are the effects of blood pressure lowering treatment diminishing?: meta-regression analyses. Clin Hypertens. 2018;24:16.

Article  PubMed  PubMed Central  Google Scholar 

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.

Article  CAS  PubMed  Google Scholar 

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63.

Article  CAS  PubMed  Google Scholar 

Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693–708.

Article  CAS  PubMed  Google Scholar 

Tanriver-Ayder E, Faes C, van de Casteele T, McCann SK, Macleod MR. Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research. BMJ Open Sci. 2021;5:e100074.

Article  PubMed  PubMed Central  Google Scholar 

Whittingham MJ, Stephens PA, Bradbury RB, Freckleton RP. Why do we still use stepwise modelling in ecology and behaviour? J Anim Ecol. 2006;75:1182–9.

Article  PubMed  Google Scholar 

Cinar O, Umbanhowar J, Hoeksema JD, Viechtbauer W. Using information-theoretic approaches for model selection in meta-analysis. Res Synth Methods. 2021;12:537–56.

Article  PubMed  PubMed Central  Google Scholar 

Anderson DR. Model based inference in the life sciences: a primer on evidence. New York: Springer; 2008.

Book  Google Scholar 

Bolker BM. Ecological models and data in R: Princeton University Press; 2008.

Harrer M, Cuijpers P, Furukawa T, Ebert D. Doing meta-analysis with R: a hands-on guide. New York: Chapman and Hall/CRC; 2021.

Book  Google Scholar 

Broderick T, Giordano R, Meager R. An automatic finite-sample robustness metric: can dropping a little data change conclusions? arXiv.org. 2021;https://arxiv.org/abs/2011.14999.

Arregoces. L, Fernández. J, Rojas-Botero. M, Palacios-Clavijo. A, M. Galvis LER, Pinto-Álvarez. M, et al. Effectiveness of COVID-19 vaccines in preventing hospitalizations and deaths in colombia: a pair-matched, national-wide cohort study in older adults. SSRN. 2021; http://dx.doi.org/https://doi.org/10.2139/ssrn.3944059.

Hitchings MDT, Ranzani OT, Torres MSS, de Oliveira SB, Almiron M, Said R, et al. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: a test-negative case-control study. Lancet Reg Health Am. 2021;1:100025.

PubMed  PubMed Central  Google Scholar 

Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385:875–84.

Article  CAS  PubMed  Google Scholar 

Ranzani OT, Hitchings MDT, Dorion M, D’Agostini TL, de Paula RC, de Paula OFP, et al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021;374:n2015.

Article  PubMed  Google Scholar 

Suah JL, Tok PSK, Ong SM, Husin M, Tng BH, Sivasampu S, et al. PICK-ing Malaysia’s epidemic apart: effectiveness of a diverse COVID-19 vaccine portfolio. Vaccines (Basel). 2021;9:1381.